Diabetes por inmunoterapia

Manzano, Natalia; Ocampo, Paloma; Nicolini, Carla; Halac, Sebastián; Aguirre, Marina; Rivero, Sergio; Zylberman, Marcelo.
Medicina (B.Aires) ; 78(1): 59-61, feb. 2018.
Artículo en Español | LILACS | ID: biblio-894552

Documentos relacionados

  1. Immunotherapy for type 1 diabetes mellitus by adjuvant-free Schistosoma japonicum-egg tip-loaded asymmetric microneedle patch (STAMP).
  2. [Diabetes by immunotherapy].
  3. [Immunological disorders in patients with purulent-inflammatory pathology of ENT organs in conditions of comorbidity with diabetes mellitus].
  4. Association between treatment effect on C-peptide preservation and HbA1c in meta-analysis of glutamic acid decarboxylase (GAD)-alum immunotherapy in recent-onset type 1 diabetes.
  5. Trispecific antibodies offer a third way forward for anticancer immunotherapy.
  6. Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes.
  7. Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes.
  8. Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple ß-Cell Peptides in Type 1 Diabetes.
  9. Immunomodulatory Effect of Vitamin D and Its Potential Role in the Prevention and Treatment of Type 1 Diabetes Mellitus-A Narrative Review.
  10. Emerging Anti-Diabetic Drugs for Beta-Cell Protection in Type 1 Diabetes.